YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQWL8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,591
Award facts
- Contract value 100% obligated
- $12,590.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,590.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. This firm fixed-price delivery order, awarded on January 23, 2026, with an ultimate completion date of February 13, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. The award was issued without any identified subcontractors.
This delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy. DMS Pharmaceutical Group holds a single-award IDC (contract SPE2DR) valued at $499,999,999 through December 31, 2036, which authorizes the DLA to issue delivery orders for a comprehensive range of pharmaceutical products including vaccines, biologics, and medical consumables to support Department of Defense healthcare operations globally. The company's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQWL8?
SPE2DR26FQWL8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FQWL8 worth?
The government has obligated $12,591 on SPE2DR26FQWL8.
Is contract SPE2DR26FQWL8 an order under another contract?
Yes. SPE2DR26FQWL8 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWL8 competed?
The extent of competition for SPE2DR26FQWL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award